Higher DSC3 expression in tumors with mutant p53 compared to wild-type p53, as seen in this study, is also described in squamous maxillary cancer and is contrary to its expression in lung cancer, colorectal, and unmethylated breast cancer [4,29,30,31,32]. This evidence concerns the gene TP53 and lung carcinoma.